Correlation Between Vanguard Health and Franklin Genomic
Can any of the company-specific risk be diversified away by investing in both Vanguard Health and Franklin Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanguard Health and Franklin Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanguard Health Care and Franklin Genomic Advancements, you can compare the effects of market volatilities on Vanguard Health and Franklin Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanguard Health with a short position of Franklin Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanguard Health and Franklin Genomic.
Diversification Opportunities for Vanguard Health and Franklin Genomic
0.97 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Vanguard and Franklin is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding Vanguard Health Care and Franklin Genomic Advancements in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Genomic Adv and Vanguard Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanguard Health Care are associated (or correlated) with Franklin Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Genomic Adv has no effect on the direction of Vanguard Health i.e., Vanguard Health and Franklin Genomic go up and down completely randomly.
Pair Corralation between Vanguard Health and Franklin Genomic
Considering the 90-day investment horizon Vanguard Health Care is expected to generate 0.56 times more return on investment than Franklin Genomic. However, Vanguard Health Care is 1.77 times less risky than Franklin Genomic. It trades about -0.13 of its potential returns per unit of risk. Franklin Genomic Advancements is currently generating about -0.08 per unit of risk. If you would invest 27,264 in Vanguard Health Care on August 26, 2024 and sell it today you would lose (681.00) from holding Vanguard Health Care or give up 2.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Vanguard Health Care vs. Franklin Genomic Advancements
Performance |
Timeline |
Vanguard Health Care |
Franklin Genomic Adv |
Vanguard Health and Franklin Genomic Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vanguard Health and Franklin Genomic
The main advantage of trading using opposite Vanguard Health and Franklin Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanguard Health position performs unexpectedly, Franklin Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Genomic will offset losses from the drop in Franklin Genomic's long position.Vanguard Health vs. Vanguard Consumer Staples | Vanguard Health vs. Vanguard Financials Index | Vanguard Health vs. Vanguard Information Technology | Vanguard Health vs. Vanguard Consumer Discretionary |
Franklin Genomic vs. Artec Consulting Corp | Franklin Genomic vs. Franklin Disruptive Commerce | Franklin Genomic vs. Photronics | Franklin Genomic vs. Global X Genomics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |